Oncotarget
The cover for issue 8 of Oncotarget features Figure 8, "MLN4924 treatment induces DNA damage by stabilizing CDT1 and accumulates the cells in S phase which are enhanced by MLN4924/cisplatin co-treatment," by Misra, et al.
EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis |
https://doi.org/10.18632/oncotarget.27374 Raphaël Bergès, Aurélie Tchoghandjian, Arnauld Sergé, Stéphane Honoré, Dominique Figarella-Branger, Felix Bachmann, Heidi A. Lane, and Diane Braguer |
759-774 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma |
https://doi.org/10.18632/oncotarget.27437 Sonali Joshi, Shawn Campbell, Jeong Y. Lim, Shannon McWeeney, Adam Krieg, Yukie Bean, Nadja Pejovic, Paulette Mhawech-Fauceglia, and Tanja Pejovic |
775-783 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment |
https://doi.org/10.18632/oncotarget.27485 Shrilekha Misra, Xiaoli Zhang, Nissar Ahmad Wani, Steven Sizemore, and Alo Ray |
784-800 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism |
https://doi.org/10.18632/oncotarget.27486 Valeria Santoro, Ilya Kovalenko, Kim Vriens, Stefan Christen, Andreas Bernthaler, Andrea Haegebarth, Sarah-Maria Fendt, and Sven Christian |
801-812 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer |
https://doi.org/10.18632/oncotarget.27491 Atsushi Tanaka, Yihua Zhou, Jinru Shia, Fiona Ginty, Makiko Ogawa, David S. Klimstra, Ronald C. Hendrickson, Julia Y. Wang, and Michael H. Roehrl |
813-824 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis |
https://doi.org/10.18632/oncotarget.27370 Minzhi Hou, Zhiqiang Cheng, Hongwei Shen, Shanyang He, Yang Li, Yunping Pan, Chongjin Feng, Xinlin Chen, Yang Zhang, Millicent Lin, Liantang Wang, and Zunfu Ke |
825-826 |
Correction | PDF | How to cite |
Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1 |
https://doi.org/10.18632/oncotarget.27484 Linda Pudelko, Pegah Rouhi, Kumar Sanjiv, Helge Gad, Christina Kalderén, Andreas Höglund, Massimo Squatrito, Alberto J. Schuhmacher, Steven Edwards, Daniel Hägerstrand, Ulrika Warpman Berglund, Thomas Helleday, and Lars Bräutigam |
827-827 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC